Polanco Returns as Mets Reshape Roster; Timing Matters for Lineup Depth
By Ty Whitney ·
Jorge Polanco's activation from the 60-day IL arrives at a critical juncture for New York's infield, but his conditioning window and recent injury history create near-term volatility in team total projections.
The Mets activated infielder Jorge Polanco from the 60-day injured list on Tuesday, reinstating him to the active roster for tonight's game. Right-hander Alex Carrillo was designated for assignment to create the necessary 40-man roster spot, while infielder Ronny Mauricio was optioned to Triple-A Syracuse to clear a 26-man spot. The timing places Polanco's return roughly two months into the season, a window that typically requires a structured ramp-up before a player reaches full offensive production.
Polanco's injury history cuts both ways for roster construction. He represents the infield depth the Mets have lacked in stretches, but a 60-day absence means his conditioning is not equivalent to a player returning from a routine stint. The team's willingness to activate him now—rather than wait for extended minor league games—signals confidence in his structural recovery, but also reflects a roster need acute enough to bypass the traditional rehab timeline. This is a team making a mid-season adjustment, not executing a patient recovery protocol.
The Carrillo DFA is largely procedural; a right-hander with limited service time and no established role can be moved without significant organizational cost. Mauricio's option to Syracuse is more interesting from a depth perspective. It suggests the Mets believe they can operate without him in the majors for the next two to three weeks, freeing a bench spot for Polanco's integration. If Polanco requires extended playing time to regain rhythm—a reasonable expectation for someone off 60 days—the team's corner infield flexibility shrinks until Mauricio returns or another roster move occurs.
For prop bettors, Polanco's activation introduces execution risk into Mets team totals. A lineup that has operated without his bat suddenly absorbs a new variable with uncertain baseline production. His first week back typically carries elevated variance; he may hit into position and over-perform expectations as he searches for timing, or he may struggle as his timing lags behind pitch recognition. The market will price Polanco's return into team total lines, but it won't precisely calibrate his day-to-day output in the first five to ten games. Betting the under on Mets team totals in the next week carries some edge if the market assumes Polanco's baseline production from his career numbers; a player 60 days removed from action rarely translates historical splits into immediate impact.
Conversely, if the Mets' lineup has been severely hampered by infield availability and Polanco's bat was above-average pre-injury, the team total could move sharply higher once he settles in around day 10 of his return. The edge exists in the timing: lean unders on New York team totals for the next three to five games while Polanco's conditioning is still a variable, then reassess once the market reprices after his adjustment period concludes.